The home-grown vaccine has been developed by the Nha Trang-basedInstitute of Vaccines and Medical Biologicals (IVAC) and the Hanoi MedicalUniversity since last May, using primary chicken embryo cell culture, atechnique the institute used previously to successfully produce seasonal fluvaccines.
COVIVAC has undergone pre-clinical trials in India, the US, and Vietnam,said IVAC Director Dr Duong Huu Thai, adding that results showed that it satisfiesall conditions to be tested on humans.
The vaccine candidate demonstrated high immunogenicity duringpre-clinical trials. It was created based on studies of new SARS-CoV-2 strains,according to Dr Pham Van Tac, Director of the Ministry of Health’sAdministration of Science Technology and Training.
There will be two phases in the trial, with the first conducted on fivegroups of volunteers totalling 120 people. Each group will be given two shots28 days apart, with doses of either 1mcg, 3mcg, or 10mcg.
The volunteers, aged 18 to 59, has been recruited by the research team.
The first shot is scheduled to be injected at the Hanoi MedicalUniversity in February./.